Norway's Borregaard Q1 revenue slightly beats, EBITDA misses estimates on cost pressure

BORREGAARD ASA

29/04/2026 06:19

Overview

Norway specialty chemicals producer's Q1 revenue slightly beat analyst expectations

Q1 EBITDA missed analyst expectations amid continued cost pressure

BioSolutions impacted by temporary value chain delays and customer destocking

Outlook

Company says it is implementing targeted measures to address continued cost pressure

Result Drivers

BIOSOLUTIONS DELAYS - Lower sales volumes in BioSolutions due to temporary value chain delays, geopolitical factors, and customer destocking, partly offset by higher sales prices

FINE CHEMICALS GROWTH - Higher deliveries and favourable product mix in Fine Chemicals drove improved results

COST PRESSURE - Continued cost pressure affected overall results, partly driven by geopolitical developments, per CEO

Company press release: ID:nGNE2BFhNH

Key Details

Metric
Beat/Miss
Actual
Consensus Estimate
Q1 Revenue
Beat
NOK 2.005 bln
NOK 1.97 bln (4 Analysts)
Q1 EPS
NOK 1.82
Q1 EBITDA
Miss
NOK 428 mln
NOK 512.80 mln (5 Analysts)
Q1 Pretax Profit
NOK 230 mln


Analyst Coverage

The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 5 "strong buy" or "buy", 3 "hold" and no "sell" or "strong sell"

The average consensus recommendation for the specialty chemicals peer group is "buy"

Wall Street's median 12-month price target for Borregaard ASA is NOK192.00, about 15.2% above its April 28 closing price of NOK166.60

The stock recently traded at 16 times the next 12-month earnings vs. a P/E of 19 three months ago

For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.

(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)